Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2023

Open Access 01-12-2023 | Research

Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study

Authors: Jinma Ren, Paul Cislo, Joseph C. Cappelleri, Patrick Hlavacek, Marco DiBonaventura

Published in: BMC Medical Research Methodology | Issue 1/2023

Login to get access

Abstract

Objectives

To have confidence in one's interpretation of treatment effects assessed by comparing trial results to external controls, minimizing bias is a critical step. We sought to investigate different methods for causal inference in simulated data sets with measured and unmeasured confounders.

Methods

The simulated data included three types of outcomes (continuous, binary, and time-to-event), treatment assignment, two measured baseline confounders, and one unmeasured confounding factor. Three scenarios were set to create different intensities of confounding effect (e.g., small and blocked confounding paths, medium and blocked confounding paths, and one large unblocked confounding path for scenario 1 to 3, respectively) caused by the unmeasured confounder. The methods of g-computation (GC), inverse probability of treatment weighting (IPTW), overlap weighting (OW), standardized mortality/morbidity ratio (SMR), and targeted maximum likelihood estimation (TMLE) were used to estimate average treatment effects and reduce potential biases.

Results

The results with the greatest extent of biases were from the raw model that ignored all the potential confounders. In scenario 2, the unmeasured factor indirectly influenced the treatment assignment through a measured controlling factor and led to medium confounding. The methods of GC, IPTW, OW, SMR, and TMLE removed most of bias observed in average treatment effects for all three types of outcomes from the raw model. Similar results were found in scenario 1, but the results tended to be biased in scenario 3. GC had the best performance followed by OW.

Conclusions

The aforesaid methods can be used for causal inference in externally controlled studies when there is no large, unblockable confounding path for an unmeasured confounder. GC and OW are the preferable approaches.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hatswell AJ, Baio G, Berlin JA, Irs A, Freemantle N. Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014. BMJ Open. 2016;6(6):e011666. Published Online First: Epub Date.CrossRef Hatswell AJ, Baio G, Berlin JA, Irs A, Freemantle N. Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014. BMJ Open. 2016;6(6):e011666. Published Online First: Epub Date.CrossRef
12.
go back to reference Chatton A, Le Borgne F, Leyrat C, et al. G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study. Sci Rep. 2020;10(1):9219. https://doi.org/10.1038/s41598-020-65917-x. Published Online First: Epub Date.CrossRef Chatton A, Le Borgne F, Leyrat C, et al. G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study. Sci Rep. 2020;10(1):9219. https://​doi.​org/​10.​1038/​s41598-020-65917-x. Published Online First: Epub Date.CrossRef
30.
go back to reference Santa-Maria CA, Bardia A, Blackford AL, et al. A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. Breast Cancer Res Treat. 2018;171(1):121–9. https://doi.org/10.1007/s10549-018-4811-1. Published Online First: Epub Date.CrossRef Santa-Maria CA, Bardia A, Blackford AL, et al. A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. Breast Cancer Res Treat. 2018;171(1):121–9. https://​doi.​org/​10.​1007/​s10549-018-4811-1. Published Online First: Epub Date.CrossRef
Metadata
Title
Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study
Authors
Jinma Ren
Paul Cislo
Joseph C. Cappelleri
Patrick Hlavacek
Marco DiBonaventura
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2023
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-023-01835-6

Other articles of this Issue 1/2023

BMC Medical Research Methodology 1/2023 Go to the issue